Mark Germain
Presidente presso SCINAI IMMUNOTHERAPEUTICS LTD.
Profilo
Mark S.
Germain is the founder of Chromadex Corp.
(founded in 1999) and The Aentib Group (founded in 2014).
He held the title of Independent Non-Executive Director at Chromadex Corp.
from 1999 to 2015.
Currently, Mr. Germain holds the position of Chairman at Amphioxus Cell Technologies, Inc., Scinai Immunotherapeutics Ltd., Omnimmune Corp., and The Aentib Group, Inc. He also serves as Managing Director at The Aentib Group, Inc. Mr. Germain's former positions include Chairman at Stem Cell Innovations, Inc., Collexis Holdings, Inc., and Omnimmune Holdings, Inc. He was also a Director at Interferon Sciences, Inc. in 2006.
Mr. Germain has a law degree from New York University School of Law, which he obtained in 1975.
Posizioni attive di Mark Germain
| Società | Posizione | Inizio |
|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Presidente | 30/09/2019 |
| The Aentib Group, Inc. | Corporate Officer/Principal | 01/01/2014 |
Omnimmune Corp.
 Omnimmune Corp. Medical/Nursing ServicesHealth Services Omnimmune Corp. develops cancer treatment including prophylactic and therapeutic vaccines, monoclonal antibodies, and gene-based products. The company was founded in 1994 and is headquartered in Halifax, NS. | Direttore/Membro del Consiglio | 01/01/2006 |
| The Olmsted Group | Corporate Officer/Principal | - |
Amphioxus Cell Technologies, Inc.
 Amphioxus Cell Technologies, Inc. BiotechnologyHealth Technology Amphioxus Cell Technologies, Inc. manufactures biological drug discovery products. It develops human liver based tools from liver biology to drug disposition, viral hepatitis, plasma proteins, and cell culture models. The company was founded by James H. Kelly and Norman L. Sussman in 1995 and is headquartered in Houston, TX. | Presidente | - |
The Aentib Group
 The Aentib Group Investment ManagersFinance The Aentib Group is a venture capital firm. The private company is based in New York, NY. The company was founded by Jean Salomé, Mark S. Germain. | Fondatore | 01/05/2014 |
Precedenti posizioni note di Mark Germain
| Società | Posizione | Fine |
|---|---|---|
| PLURI INC. | Direttore/Membro del Consiglio | 21/06/2022 |
| CHROMADEX CORPORATION | Fondatore | 20/04/2015 |
ChromaDex, Inc.
 ChromaDex, Inc. Miscellaneous Commercial ServicesCommercial Services ChromaDex, Inc. supplies phytochemical reference standards. It also provides the tools necessary to maintain quality and control of the market databases services. The company was co-founded by Frank Jaksch & Mark S. Germain in 1999 and is located in Irvine, CA. | Direttore/Membro del Consiglio | 15/07/2008 |
| ░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Mark Germain
| New York University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| PLURI INC. | Health Technology |
| COLLEXIS HOLDINGS INC. | Technology Services |
| CHROMADEX CORPORATION | Health Technology |
| OMNIMMUNE HOLDINGS, INC. | Health Technology |
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Aziende private | 13 |
|---|---|
| Interferon Sciences, Inc. | Health Technology |
Wellsford Residential Property Trust
 Wellsford Residential Property Trust Real Estate Investment TrustsFinance Part of Equity Residential, Wellsford Residential Property Trust is a real estate investment trust. The company is based in New York, NY. The company was founded by Edward Lowenthal. Wellsford Residential Property Trust was acquired by Equity Residential on May 30, 1997 for $506 million. | Finance |
| Wellsford Real Properties, Inc. | Finance |
Intellect Neurosciences, Inc.
 Intellect Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Intellect Neurosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of disease-modifying therapeutic agents. It specializes in treatment and prevention of neurodegenerative conditions, collectively known as proteinopathies, which include alzheimer's, parkinson's and huntington disease. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Omnimmune Corp.
Omnimmune Corp. Medical/Nursing ServicesHealth Services Omnimmune Corp. develops cancer treatment including prophylactic and therapeutic vaccines, monoclonal antibodies, and gene-based products. The company was founded in 1994 and is headquartered in Halifax, NS. | Health Services |
ChromaDex, Inc.
ChromaDex, Inc. Miscellaneous Commercial ServicesCommercial Services ChromaDex, Inc. supplies phytochemical reference standards. It also provides the tools necessary to maintain quality and control of the market databases services. The company was co-founded by Frank Jaksch & Mark S. Germain in 1999 and is located in Irvine, CA. | Commercial Services |
Nortrax, Inc.
 Nortrax, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Nortrax, Inc. manufactures industrial and construction equipment. It also offers financing and specialized field services for contractors in the timber harvesting and construction industries. The company is headquartered in Tampa, FL. | Producer Manufacturing |
Stem Cell Innovations, Inc.
 Stem Cell Innovations, Inc. Miscellaneous Commercial ServicesCommercial Services Stem Cell Innovations, Inc. conducts pharmacological research based on stem cells. The company was is headquartered in Houston, TX. | Commercial Services |
Amphioxus Cell Technologies, Inc.
Amphioxus Cell Technologies, Inc. BiotechnologyHealth Technology Amphioxus Cell Technologies, Inc. manufactures biological drug discovery products. It develops human liver based tools from liver biology to drug disposition, viral hepatitis, plasma proteins, and cell culture models. The company was founded by James H. Kelly and Norman L. Sussman in 1995 and is headquartered in Houston, TX. | Health Technology |
Reis, Inc.
 Reis, Inc. Internet Software/ServicesTechnology Services Reis, Inc. engages in the provision of commercial real estate performance information and analysis. The firm’s solutions include analytics, API, CECL, custom, data and reporting, portfolio CRE and property search solutions. It serves acquisitions, brokerage, development, lending, press, valuation and advisory industries. The company was founded by Lloyd Lynford and Jonathan Garfield in 1980 and is headquartered in New York, NY. | Technology Services |
| The Olmsted Group | |
| The Aentib Group, Inc. | |
The Aentib Group
The Aentib Group Investment ManagersFinance The Aentib Group is a venture capital firm. The private company is based in New York, NY. The company was founded by Jean Salomé, Mark S. Germain. | Finance |
- Borsa valori
- Insiders
- Mark Germain
